Claim CME Credit

MAXIMUM 17.25 CREDITS AVAILABLE

EDUCATIONAL OBJECTIVES:

After completing this activity, the participant should be better able to:

Analyze the natural history of motor fluctuations in Parkinson’s disease and apply evidence-based strategies to manage motor complications, including optimizing medication regimens and selecting appropriate adjunctive therapies.
Recognize and assess common neuropsychiatric and non-motor features associated with movement and neurodegenerative disorders and select evidence-based approaches for their diagnosis and management.
Determine when advanced therapies should be considered and evaluate current evidence and clinical considerations for deep brain stimulation, infusion therapies, focused ultrasound, and other device-aided treatments.
Interpret biomarker and neurodiagnostic data to differentiate among neurodegenerative disorders and integrate this information to inform individualized patient care.
Differentiate among common hyperkinetic disorders based on clinical features and select evidence-based treatments appropriate to each condition.
Evaluate diagnostic and therapeutic strategies for Alzheimer’s disease, Lewy body dementia, and Parkinson’s disease dementia, including the role of pathology-targeted and emerging disease-modifying therapies in clinical decision-making.
Apply evidence-based procedural principles to the safe and effective use of botulinum toxin and other interventional treatments, including patient selection, anatomical targeting, and technique-guided administration.

Credit Designation: Continuing Medical Education

PMD Alliance designates this activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™.

Learners should claim only the credit commensurate with the extent of their participation in the activity.

ACCREDITATION STATEMENT: In support of improving patient care, this activity has been planned and implemented by PMD Alliance. PMD Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DISCLOSURE OF CONFLICTS OF INTEREST: Parkinson and Movement Disorder Alliance (PMD Alliance) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.

PMD Alliance is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All identified conflicts of interest are thoroughly vetted and mitigated according to PMD Alliance CME Program standard operating procedures.

COMMERCIAL SUPPORT: This activity is supported by independent medical education grants from Acadia, Merz, Supernus, Abbott, Boston Scientific, Ipsen, GE HealthCare. This activity is also supported with in-kind contributions and training supplies from Merz, Supernus, Ipsen, Revance, Ambu, and Cadwell.

REQUEST FOR CREDIT: To claim credit for your participation and obtain your certificate, please follow the directions provided through your convention app. If you have questions regarding the certification of this activity, please contact PMD Alliance at education@pmdalliance.org.

CLAIM CREDIT